Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
FL.15.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.40EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CR.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KB.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GK.11EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CJ.1.3.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XANEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BN.1.4.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AZ.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.97EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.36.18EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.177.32EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.59EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.177.67EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.277EWon-ECACACAATCGATGCGCAGTA20502636526346R-2361.24South Korea
AY.28 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.272EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.371EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AA.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.353EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.407EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AA.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.160.13EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.47EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.182EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.218EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.12.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
A.11EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.22 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.128EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.254EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.39.1.1 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.418EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.9.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.40EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.122EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XAJEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.431EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.168EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Q.6 (Alpha)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBF.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.343EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.4.17 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.25.1.2 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.409EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.83EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.310EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.362.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.162EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Y.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used